Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Full conference information obtained from the Annual cancer conference program and abstracts. See ID# 15548. (QZ200 B366 2006)
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Full conference information obtained from the Annual cancer conference program and abstracts. See ID# 16603 (QZ200 B366 2007)
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Living with Cancer: A Report on the Patient Experience, is the first in a series looking at Canadian cancer care exclusively from the patient perspective, illustrating the experience of those individuals and families living with and beyond cancer. This groundbreaking report includes data drawn from…
Brain; Breast; Gastro-intestinal; Genito-urinary; Gynecologic; Head and neck; Hematologic; IND; Lung; Melanoma; Sarcoma; Symptom control
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; Chapter 1 -- Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer -- Chapter 2 Monoclonal Antibody Therapy -- Chapter 3 Somatic Mutations and Immunotherapy -- Chapter 4 Checkpoint Blockade -- Chapter 5 Myeloid Leukemia…